- Home
- DYAI vs IRIX Comparison
DYAI vs IRIX Comparison
Compare DYAI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYAI | IRIX |
|---|---|---|
| Founded | 1979 | 1989 |
| Country | United States | United States |
| Employees | N/A | 120 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8M | 23.0M |
| IPO Year | 2003 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DYAI | IRIX |
|---|---|---|
| Price | $0.80 | $1.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 66.4K | 38.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.47 |
| EPS | ★ N/A | N/A |
| Revenue | $3,495,389.00 | ★ $41,593,000.00 |
| Revenue This Year | $12.52 | $9.61 |
| Revenue Next Year | $92.04 | $8.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 20.58 | N/A |
| 52 Week Low | $0.71 | $0.78 |
| 52 Week High | $1.55 | $1.65 |
Technical Indicators
Market Signals| Indicator | DYAI | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 44.54 |
| Support Level | $0.73 | $1.04 |
| Resistance Level | $0.87 | $1.56 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 33.77 | 33.33 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.